260 results on '"Rieder, Florian"'
Search Results
2. HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis
3. The Future of Precision Medicine to Predict Outcomes and Control Tissue Remodeling in Inflammatory Bowel Disease
4. The Origin and Contribution of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis
5. EVALUATION OF CLINICAL VARIABLES, RADIOLOGICAL VISUAL ANALOG SCORING, AND RADIOMICS FEATURES ON CT ENTEROGRAPHY FOR CHARACTERIZING SEVERE INFLAMMATION AND FIBROSIS IN STRICTURING CROHN’S DISEASE
6. A Summary of the BRIDGe Summit on Damage-Related Progression of Ulcerative Colitis: Establishing Research Priorities
7. 719: POSTOPERATIVE CROHN'S DISEASE RECURRENCE RISK AND OPTIMAL BIOLOGIC TIMING AFTER TEMPORARY DIVERSION FOLLOWING ILEOCECAL RESECTION
8. 587: EPIDEMIOLOGY AND RISK FACTORS ASSOCIATED WITH MALE SEXUAL DYSFUNCTION IN PATIENTS WITH ILEO-ANAL POUCH ANASTOMOSIS
9. Tu1479: NORMALISATION OF BIOMARKERS AND IMPROVEMENT IN CLINICAL OUTCOMES IN PATIENTS WITH CROHN'S DISEASE TREATED WITH RISANKIZUMAB IN THE PHASE 3 ADVANCE, MOTIVATE, AND FORTIFY STUDIES
10. 720: EARLY INITIATION OF ANTI-TUMOR NECROSIS FACTOR THERAPY REDUCES POSTOPERATIVE RECURRENCE OF CROHN'S DISEASE FOLLOWING ILEOCECAL RESECTION
11. Sa1595: AN EXPERT CONSENSUS TO STANDARDIZE DEFINITIONS AND MANAGEMENT FOR EXTRA-INTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE
12. Sa1591: INTRAABDOMINAL SEPTIC COMPLICATIONS AFTER ILEOCOLIC RESECTION INCREASES ENDOSCOPIC POSTOPERATIVE CROHN'S DISEASE RECURRENCE
13. Mo1555: PRE-OPERATIVE USE OF MULTIPLE BIOLOGIC AND SMALL MOLECULE DRUGS IS NOT ASSOCIATED WITH SUBSEQUENT ENDOSCOPIC INFLAMMATORY POUCH DISEASES
14. 456: CHRONOLOGIC AGE IS NOT ASSOCIATED WITH RISK OF POSTOPERATIVE RECURRENCE IN CROHN'S DISEASE
15. Mo1462: DEVELOPMENT OF A MAGNETIC RESONANCE ENTEROGRAPHY INDEX FOR ASSESSING SMALL BOWEL STRICTURES IN PATIENTS WITH CROHN'S DISESE: VALIDATION OF METHODS AND ITEM RELIABILITY
16. Mo1563: POST-OPERATIVE IMMUNOSUPPRESSIVE THERAPY FOLLOWING ILEAL POUCH ANAL ANASTOMOSIS CREATION: AN ASSESSMENT USING THE TRINETX COHORT
17. 401: ANASTOMOTIC CONFIGURATION AND DIVERTING OSTOMY DOES NOT INCREASE THE RISK OF POSTOPERATIVE ANASTOMOTIC STRICTURES IN CROHN'S DISEASE
18. Sa1842 INFLAMMATORY BOWEL DISEASE ACTIVITY IS ASSOCIATED WITH LARGE JOINT PERIPHERAL SPONDYLOARTHRITIS, BUT NOT WITH THE NUMBER OF INVOLVED JOINTS
19. Mo1784 HIGH-RESOLUTION IMPEDANCE PLANIMETRY CHARACTERIZES THE MECHANICAL FEATURES OF CROHN'S DISEASE STRICTURES – IMPLICATIONS FOR PATIENT STRATIFICATION
20. Su1740 TOPICAL SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR 1 MODULATION REGULATES GUT ANGIOGENESIS IN INFLAMMATORY BOWEL DISEASES
21. Sa1267 ESOPHAGEAL LUMINAL DIAMETER IS ASSOCIATED WITH DYSPHAGIA IN EOSINOPHILIC ESOPHAGITIS: IMPLICATIONS FOR ENDOSCOPIC DILATION THERAPY
22. 1142 INTEGRIN INHIBITION REDUCES PROFIBROTIC RESPONSES IN CROHN'S DISEASE (CD) HUMAN INTESTINAL MYOFIBROBLASTS IN VITRO AND AMELIORATES EXPERIMENTAL INTESTINAL FIBROSIS IN VIVO - A POTENTIAL NOVEL APPROACH TO CD STRICTURE THERAPY
23. Sa1881 MICROBIAL TRIMETHYLAMINE EXERTS PROFIBROTIC PROPERTIES IN IBD - IMPLICATIONS FOR NOVEL ANTI-FIBROTIC THERAPIES
24. Sa1199 CONDENSINS ARE UPREGULATED IN CROHN'S DISEASE PATIENT ILEAL EPITHELIAL CELLS AND PROMOTE INTESTINAL PERMEABILITY
25. 963 THE BREATH METABOLOME SIGNATURE IS LINKED WITH DIAGNOSIS OF EOSINOPHILIC ESOPHAGITIS: PILOT STUDY ASSESSING EXHALED VOLATILE ORGANIC COMPOUNDS
26. 760 TRANSGLUTAMINASE 2 IS ELEVATED IN CROHN'S DISEASE ASSOCIATED STRICTURES AND EXERTS PROFIBROTIC ACTIVITIES IN MYOFIBROBLASTS AND EXPERIMENTAL INTESTINAL FIBROSIS
27. Tu1740 LOCAL BIOACTIVATION AND EFFICACY OF PALI-2108: A PROMISING PDE4 INHIBITOR PRODRUG FOR ULCERATIVE COLITIS TREATMENT
28. 173 DUAL ACTIVATION OF GCGR/GLP1R SIGNALING AMELIORATES INTESTINAL FIBROSIS VIA METABOLIC REGULATION OF HISTONE H3K9 LACTYLATION IN EPITHELIAL CELLS
29. Mo1763 POSTOPERATIVE RECURRENCE IN INFLAMMATORY BOWEL DISEASE ASSOCIATED PERMANENT END ILEOSTOMY: A SYSTEMATIC REVIEW
30. Su1770 EFFECT OF RISANKIZUMAB ON EARLY SYMPTOMS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: A POST-HOC ANALYSIS OF THE INSPIRE INDUCTION STUDY
31. 1095 EXHALED BREATH ANALYSIS OF VOLATILE ORGANIC COMPOUNDS IS ASSOCIATED WITH LUMINAL DISEASE ACTIVITY IN PATIENTS WITH ULCERATIVE COLITIS
32. Not Hard to Swallow—Understanding Endothelial-Fibroblast Crosstalk in Eosinophilic Esophagitis
33. Challenges in the Pathophysiology, Diagnosis, and Management of Intestinal Fibrosis in Inflammatory Bowel Disease
34. An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials
35. Development and Validation of a Novel Computed-Tomography Enterography Radiomic Approach for Characterization of Intestinal Fibrosis in Crohn’s Disease
36. 722 INCREASED LEVELS OF CADHERIN-11 EXPRESSION IN IBD PROMOTE FIBROBLAST ACTIVATION AND EXPERIMENTAL INTESTINAL FIBROSIS BUT NOT COLITIS ASSOCIATED CANCER
37. 723 INFLAMMATORY BOWEL DISEASE HUMAN INTESTINAL MYOFIBROBLASTS DEPOSIT EXTRACELLULAR MATRIX WITH ENHANCED ADHESIVENESS FOR T-CELLS – A NOVEL MECHANISM FOR MAINTENANCE OF INTESTINAL INFLAMMATION
38. Sa580 REAL-WORLD EFFECTIVENESS AND SAFETY OF USTEKINUMAB AND VEDOLIZUMAB IN ELDERLY PATIENTS WITH CROHN'S DISEASE
39. 387 SEPTIN CYTOSCELETON IS A NOVEL REGULATOR OF INTESTINAL FIBROGENESIS
40. Su504 FLAGELLIN STIMULATION OF HUMAN INTESTINAL MYOFIBROBLASTS INDUCES CASPASE-1 ACTIVATION DRIVING FIBRONECTIN PRODUCTION – A NOVEL, TARGETABLE MECHANISM OF INTESTINAL FIBROSIS
41. Sa462 ACCURACY OF IMAGING IN DETECTING POSTOPERATIVE CROHN'S DISEASE RECURRENCE
42. Sa545 STRICTURE LENGTH, DURATION AND OBSTRUCTIVE SYMPTOMS PREDIT TIME TO INTERVENTION IN CROHN'S DISEASE – A DERIVATION AND VALIDATION STUDY
43. Su479 FIBROSTENOTIC CROHN'S DISEASE MESENCHYMAL CELLS ARE RESISTANT TO THE ANTI-FIBROTIC ACTIVITY OF MILK FAT GLOBULE-EGF FACTOR 8 (MFGE8)
44. Sa673 TWISTED POUCH SYNDROME - A DIFFICULT TO DIAGNOSE MECHANICAL COMPLICATION OF ILEAL POUCH-ANAL ANASTOMOSIS: OUTCOMES AFTER REDO POUCH PROCEDURES
45. Fr513 INCIDENCE OF INFECTIONS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS TREATED WITH OZANIMOD AND RELATIONSHIP TO SIGNIFICANT LYMPHOPENIA: RESULTS FROM A POOLED SAFETY ANALYSIS
46. Su487 VEDOLIZUMAB AND USTEKINUMAB FOR THE TREATMENT OF SYMPTOMATIC SMALL BOWEL STRICTURING CROHN'S DISEASE - RESULTS FROM AN OBSERVATIONAL COHORT STUDY
47. Sa496 CROHN'S DISEASE PREDISPOSES TO LIVER FIBROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE. A PROPENSITY MATCHED ANALYSIS.
48. Sa546 WORSE OUTCOMES AND HIGHER COSTS OF CARE FOR PATIENTS WITH FIBROSTENOTIC CROHN'S DISEASE: A REAL-WORLD PROPENSITY-MATCHED ANALYSIS IN THE USA
49. Su480 ACTIVATED INTESTINAL MUSCLE PROMOTES PREADIPOCYTE MIGRATION: A NOVEL MECHANISM OF CREEPING FAT FORMATION IN CROHN'S DISEASE
50. Su484 AN INTERNATIONAL CONSENSUS TOWARD STANDARDIZATION OF HISTOPATHOLOGIC SCORING FOR SMALL BOWEL STRICTURES IN CROHN'S DISEASE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.